4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-,(2S,5R,6R)- cas no:61-72-3
Synonyms: 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-(8CI);6-(3-o-Chlorophenyl-5-methylisoxazol-4-ylamido) penicillanic acid;6-(5-Methyl-3-o-chlorophenylisoxazole-4-carboxamido) penicillanic acid;6-[3-(o-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid;6-[3-(o-Chlorophenyl)-5-methyl-4-isoxazolylcarboxamido]penicillanic acid;BRL1621;Methocillin S;Orbenin Extra Dry Cow;Syntarpen;
Name4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-,(2S,5R,6R)-
CAS61-72-3
Synonyms4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-(8CI);6-(3-o-Chlorophenyl-5-methylisoxazol-4-ylamido) penicillanic acid;6-(5-Methyl-3-o-chlorophenylisoxazole-4-carboxamido) penicillanic acid;6-[3-(o-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid;6-[3-(o-Chlorophenyl)-5-methyl-4-isoxazolylcarboxamido]penicillanic acid;BRL1621;Methocillin S;Orbenin Extra Dry Cow;Syntarpen;
EINECS(EC#)226-051-0,
217-428-0
Molecular FormulaC19H18ClN3O5S
Molecular Weight435.88132
Appearancewhite
to off white free flowing crystalline powder
refractive index1.685
Hazard UN
NO.
Safety
A poison by intracerebral route. Human systemic effects by ingestion: body temperature increase; interstitial nephritis; liver function tests impaired. Mutation data reported. When heated to decomposition it emits toxic vapors of SOx, NOx, and Cl−.
1. |
|
sce-hmn-lym 400 mg/L
|
|
BSIBAC Bolletino della Societe Italiana di Biologia Sperimentale. 60 (1984),2143. |
2. |
|
orl-wmn TDLo:200 mg/kg/5D-I:LVR
|
|
AJGAAR American Journal of Gastroenterology. 81 (1986),1082. |
3. |
|
orl-chd TDLo:5600 mg/kg/5W-I:SYS
|
|
IJMDAI Israel Journal of Medical Sciences. 27 (1991),159. |
4. |
|
ice-mus LD50:8100 µg/kg
|
|
NKRZAZ Chemotherapy (Tokyo). 17 (1969),1111. |